Admittance Technologies

Admittance Technologies is committed to improving the quality of life of patients with heart disease through innovative electrical engineering solutions. Admittance will accomplish this goal through the application of CardioVol™, which can interrogate the heart with electric fields, and in real-time provide ventricular volume data including relative stroke volume. We focus on the blood signal to warn patients of impending heart failure, maximize their hearts’ ejection of blood by properly tuning the pacing of these weakened hearts, and using stroke volume to determine if VT is hemodynamically unstable, requiring defibrillation.

Admittance Technologies is committed to improving the quality of life of patients with heart disease through innovative electrical engineering solutions.